116 related articles for article (PubMed ID: 20100644)
1. Circulation levels of acute phase proteins in patients with Takayasu arteritis.
Ma J; Luo X; Wu Q; Chen Z; Kou L; Wang H
J Vasc Surg; 2010 Mar; 51(3):700-6. PubMed ID: 20100644
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary study on differential expression of plasma proteins of patients with Takayasu's arteritis in different stage].
Luo XY; Wu QH; Chen Z; Ma J; Han YM; Tang XB; Wu ZM; Kou L; Liu H; Li Q; Jia YF; Zhang Z; He N
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):157-60. PubMed ID: 20356548
[TBL] [Abstract][Full Text] [Related]
3. Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis.
Wang H; Ma J; Wu Q; Luo X; Chen Z; Kou L
J Vasc Surg; 2011 Jan; 53(1):174-80. PubMed ID: 20832232
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases as novel disease markers in Takayasu arteritis.
Matsuyama A; Sakai N; Ishigami M; Hiraoka H; Kashine S; Hirata A; Nakamura T; Yamashita S; Matsuzawa Y
Circulation; 2003 Sep; 108(12):1469-73. PubMed ID: 12952836
[TBL] [Abstract][Full Text] [Related]
5. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis.
Park MC; Lee SW; Park YB; Lee SK
Rheumatology (Oxford); 2006 May; 45(5):545-8. PubMed ID: 16352633
[TBL] [Abstract][Full Text] [Related]
7. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis.
Nair AM; Goel R; Hindhumati M; Jayakanthan K; Visalakshi J; Joseph G; Danda S; Danda D
Rheumatol Int; 2017 Oct; 37(10):1643-1649. PubMed ID: 28801814
[TBL] [Abstract][Full Text] [Related]
9. Complement activation and plasma levels of C4b-binding protein in critical limb ischemia patients.
Martin M; Gottsäter A; Nilsson PM; Mollnes TE; Lindblad B; Blom AM
J Vasc Surg; 2009 Jul; 50(1):100-6. PubMed ID: 19563958
[TBL] [Abstract][Full Text] [Related]
10. Plasma proteomic screening and validation of novel biomarkers in Takayasu's arteritis.
Luo X; Zhang F; Huang Y; Wang Z; Wu Q
Clin Exp Rheumatol; 2021; 39(6):1352-1359. PubMed ID: 33769262
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
12. Antimonocyte antibodies in Takayasu's arteritis: prevalence of and relation to disease activity.
Tripathy NK; Sinha N; Nityanand S
J Rheumatol; 2003 Sep; 30(9):2023-6. PubMed ID: 12966610
[TBL] [Abstract][Full Text] [Related]
13. Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.
Steininger C; Graninger W; Zoufaly A; Zöllner B; Feucht HH; Kundi M; Stahmer I; Stellbrink HJ; van Lunzen J
Eur J Med Res; 2008 Jun; 13(6):304-8. PubMed ID: 18558558
[TBL] [Abstract][Full Text] [Related]
14. Soluble endothelial cell adhesion molecules and their relationship to disease activity in Takayasu's arteritis.
Tripathy NK; Chandran V; Garg NK; Sinha N; Nityanand S
J Rheumatol; 2008 Sep; 35(9):1842-5. PubMed ID: 18597403
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
[TBL] [Abstract][Full Text] [Related]
16. Role of C-C chemokines in Takayasu's arteritis disease.
Dhawan V; Mahajan N; Jain S
Int J Cardiol; 2006 Sep; 112(1):105-11. PubMed ID: 16647147
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.
Mayer JM; Raraty M; Slavin J; Kemppainen E; Fitzpatrick J; Hietaranta A; Puolakkainen P; Beger HG; Neoptolemos JP
Br J Surg; 2002 Feb; 89(2):163-71. PubMed ID: 11856128
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
Pertovaara M; Jylhävä J; Uusitalo H; Pukander J; Helin H; Hurme M
J Rheumatol; 2009 Nov; 36(11):2487-90. PubMed ID: 19833744
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the diagnosis of large vessel vasculitis: identification of biomarkers and imaging studies].
Villa I; Agudo Bilbao M; Martínez-Taboada VM
Reumatol Clin; 2011 Dec; 7 Suppl 3():S22-7. PubMed ID: 22119278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
